Project Grant R03AG095803
Award Date 9/22/25
Completion Date 8/31/27
Dollars Obligated $394K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
- This Project Grant award from the National Institute on Aging's Aging Research program (CFDA 93.866) provides $349,561 to The Regents of the University of California, San Francisco to conduct the "Promoting Gynecologic Cancer Patients with Frailty to Achieve Functional Recovery Cohort Study (PROOF Cohort Study)". The study aims to 1) objectively assess physical frailty in patients aged 50 and older with advanced ovarian or uterine cancer, and quantify associations with perioperative...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $624,000.00 to the University of Texas Health Science Center at Houston to explore a patient priorities care framework for improving breast cancer survivorship care for older women with multiple chronic conditions. The project aims to use this framework to identify patient priorities, incorporate them into treatment plans, and evaluate the feasibility and impact on treatment burden and quality...
- The National Institute on Aging (NIA) awarded a $243,000 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the University of Chicago. The grant, titled "BEFITME II: Applying User-Centered Co-Design and Implementation Science to Enhance Prehabilitation for Frail Older Adults Undergoing Lung Cancer Surgery," aims to develop and evaluate a technology-based prehabilitation program to improve outcomes for frail older adults undergoing lung cancer surgery. The...
- This federal Project Grant award of $420,000 from the National Institute on Aging (CFDA 93.866 Aging Research) will fund a study by Mayo Clinic Arizona to describe how older adults with indolent non-Hodgkin lymphoma experience quality of life. The study will use quantitative survey data (Aim 1) and qualitative patient interviews (Aim 2) to provide a detailed examination of the essential connections and associations for this patient population. The insights gained will inform future care...
- The National Institute on Aging (NIA), part of the U.S. Department of Health and Human Services, awarded a $111,715 project grant under the Aging Research federal grant program (CFDA 93.866) to the University of Texas Health Science Center at Houston. The goal of this 5-year project, which runs from September 2025 to May 2030, is to develop a novel computational phenotyping approach called 'CRCIPHENO' to systematically extract and standardize data on cancer-related cognitive impairment (CRCI)...
- This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) totaling $210,496 is funding research to investigate the causal role of elevated kynurenine levels and increased aryl hydrocarbon receptor (AhR) activity in the decline of physical function during aging. The award recipient, the University of Florida, will use novel genetic mouse models to test if these factors drive the deterioration of muscle and physical function with aging. This research aims to...
- The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $811,443 Project Grant to Beth Israel Deaconess Medical Center, Inc. to conduct a cluster randomized trial of a breast cancer treatment decision aid for women aged 70 and older with low-risk stage I breast cancers. The project aims to develop and test a shared decision-making program for breast surgeons and a decision aid to inform women in this population about the benefits and harms...
- This Project Grant award of $243,000.00, issued on September 5, 2025 by the National Institute on Aging (CFDA 93.866 Aging Research), supports research at the University of Pennsylvania's Clinical Practices on the impact of frailty on disease relapse and therapy intensity in older adults with acute myeloid leukemia (AML). The goal is to identify biomarkers and optimize treatment selection for this vulnerable population. The research aims to elucidate the relationship between frailty, AML disease...
- This Project Grant award of $386,612 from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support a study to investigate the contributions of social and structural determinants of health (SSDOH) to accelerated biological aging, cancer risk, and differences in frailty and mortality among cancer survivors. The study will leverage data from two well-characterized prospective studies, the Atherosclerosis Risk in Communities (ARIC) Study and the Multi-Ethnic...
- The National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded a $658,743 project grant to Kaiser Foundation Hospitals, doing business as Kaiser Permanente. The purpose of this 5-year grant, awarded on Aug 25, 2025, is to develop and validate prediction models for trajectories of function, cognition, and quality of life among adults aged 65 and older with advanced non-small cell lung cancer during chemotherapy and/or immunotherapy treatment....